| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-03 | NCT07743112 A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07743112 | A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly… | Acute Myeloid Leukemia | Recruiting |